Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.61 |
| ▸ | DRD3 | P35462 | 4/20 | 0.61 |
| ▸ | HTR1A | P08908 | 3/20 | 0.61 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.61 |
| ▸ | DRD2 | P14416 | 3/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.61 |
| ▸ | DRD1 | P21728 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16492910 | 0.91 | NOX1 (0.83) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL31425281 | 0.86 | NOX1 (0.76) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL26787361 | 0.84 | NOX1 (0.73) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL31389018 | 0.84 | NOX1 (0.73) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL4622014 | 0.83 | NOX1 (0.73) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL30725912 | 0.83 | NOX1 (0.73) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL1984394 | 0.82 | NOX1 (0.70) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL2669541 | 0.82 | NOX1 (0.70) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL9475738 | 0.81 | HTR1A (0.77) | NOX1LMNAMAPTL3MBTL1MAPK1 | |
| SCHEMBL27573856 | 0.81 | LMNA (0.68) | NOX1LMNAMAPTL3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070261806-A1 | Treatment of Pulp Stocks Using Oxidative Enzymes to Reduce Pitch Deposition | ENZYMATIC DEINKING TECHNOLOGIES, LLC | 2007-11-15 | — | — | US | claimed |
| EP-0707637-B1 | ENHANCEMENT OF LACCASE REACTIONS | NOVOZYMES AS (DK) | 2005-11-02 | — | — | EP | claimed |
| EP-1137391-B1 | METHOD FOR TREATING HAIR | NOVOZYMES AS (DK) | 2004-11-03 | — | — | EP | claimed |
| US-20040049859-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | L'OREAL S.A. (FR) | 2004-03-18 | — | — | US | claimed |
| US-20040025265-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | LANG GERARD (FR) | 2004-02-12 | — | — | US | claimed |
| US-20030159706-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | L'OREAL S.A. (FR) | 2003-08-28 | — | — | US | claimed |
| US-6572843-B1 | Combining permanent dyeing and straightening; applying to reduced hair an oxidizing enzyme (Laccase), a mediator, and a chemical oxidizing agent that produces hydrogen peroxide | NOVOZYMES, A/S (DK) | 2003-06-03 | — | — | US | claimed |
| EP-1304996-A1 | ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD | L'OREAL (FR) | 2003-05-02 | — | — | EP | claimed |
| EP-1304997-A1 | ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD | L'OREAL (FR) | 2003-05-02 | — | — | EP | claimed |
| EP-1304998-A1 | ENZYME COMPOSITION FOR BLEACHING HUMAN KERATINOUS FIBRES AND BLEACHING METHOD | L'OREAL (FR) | 2003-05-02 | — | — | EP | claimed |
| EP-0912097-A1 | ANTIMICROBIAL PEROXIDASE COMPOSITIONS | NOVO NORDISK A/S (DK) | 1999-05-06 | — | — | EP | claimed |
| US-5899212-A | CLEAVAGE OF DISULFIDE BONDS, OXIDOREDUCTASE | NOVO NORDISK A/S (DK) | 1999-05-04 | — | — | US | claimed |
| US-5885304-A | AROMATIC COMPOUNDS CONTAINING AT LEAST TWO RINGS, AT LEAST ONE SUBSTITUTED WITH NITROGEN OXYGEN, OR SULFUR | NOVO NORDISK A/S (DK) | 1999-03-23 | — | — | US | claimed |
| US-5795855-A | DETERGENTS | NOVO NORDISK A/S | 1998-08-18 | — | — | US | claimed |
| WO-1997042825-A1 | ANTIMICROBIAL PEROXIDASE COMPOSITIONS | NOVO NORDISK A/S (DK) | 1997-11-20 | — | — | WO | claimed |
| CN-1126490-A | Enhancement of laccase reactions | NOVO NORDISK AS (DK) | 1996-07-10 | — | — | CN | claimed |
| EP-0707637-A1 | ENHANCEMENT OF LACCASE REACTIONS | NOVO NORDISK A/S (DK) | 1996-04-24 | — | — | EP | claimed |
| EP-0679183-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK A/S (DK) | 1995-11-02 | — | — | EP | claimed |
| WO-1995001426-A1 | ENHANCEMENT OF LACCASE REACTIONS | NOVO NORDISK A/S (DK) | 1995-01-12 | — | — | WO | claimed |
| WO-1994012621-A1 | ENHANCEMENT OF ENZYME REACTIONS | NOVO NORDISK (DK) | 1994-06-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030159706-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | KRT18, LPO, MPO | NOX1 32/4885LMNA 1343/4885MAPT 1208/4885 |
| US-20040025265-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | KRT18, LPO, ALDH1A2 | NOX1 185/4885LMNA 2377/4885MAPT 1295/4885 |
| US-20040049859-A1 | Enzyme composition for bleaching human keratinous fibres and bleaching method | KRT18, COXFA4, LPO | NOX1 186/4885LMNA 1636/4885MAPT 1092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.